“We are excited to add House of Herbs to our growing list of clients,” says Todd Denkin, CEO of DigiPath, Inc. “They are dedicated to cultivating clean and safe cannabis products here in the State of Nevada, and we look forward to a long term partnership.”

“We were really impressed with DigiPath Labs’ customer service and eye for detail,” says a representative of House of Herbs. “We want to produce the highest quality cannabis products, and this partnership will help us gain patient trust and loyalty.”

DigiPath Labs’ state-of-the-art Las Vegas laboratory was developed to elevate the standard for cannabis testing. The team carefully selected equipment and verified standard operating procedures to ensure reliable, replicable results.

House of Herbs is a fully licensed medical cannabis cultivator located in Clark County, Nevada.

DigiPath Labs will test cannabis grown by House of Herbs for potency, terpenoids, moisture content, foreign matter, heavy metals, microbials, mycotoxins, and pesticide residue.

“Even though it’s just the beginning of the cannabis industry in Nevada, we are still leading the way with the most stringent testing when compared with other states,” says Denkin. “House of Herbs has a commitment to excellence, and we look forward to helping them help patients.”

To learn more about DigiPath Labs, visit www.digipathlabs.com.

About DigiPath, Inc.
DigiPath, Inc., supports the cannabis industry’s best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath’s two business units are DigiPath Labs and TNM News Corp.

For more information, go to www.digipath.com.

Information about Forward-Looking Statements

This press release contains “forward-looking statements” that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company’s need for additional funding, governmental regulation of the cannabis industry, the demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available atwww.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

DigiPath, Inc.
Investor Relations
702.470.2249
info@digipath.com

Logo – https://photos.prnewswire.com/prnh/20151118/288714LOGO

To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/digipath-labs-signs-cannabis-testing-agreement-with-house-of-herbs-300212491.html